Publication of the month |
Increasing research capacity in Canadian community hospitals: an intrinsic descriptive case studyDr. Alexandra Binnie, Critical Care SummaryThis study examined how targeted funding from the Canadian Critical Care Trials Group’s (CCCTG) COVID-19 Network of Clinical Trials Networks strengthened research capacity in community hospitals, using a one-year descriptive case study based on documents and interviews. Highlights
Impact
Learn moreRead the full text of this article. For questions or comments about this article, send an email to Dr. Alexandra Binnie. |
Articles
- February 23, 2026: Evaluating T-cell engager therapy: Real-world insights from Osler
- December 1, 2025: Financial hardship, chronic kidney disease, and the case for policy action in Canada
- April 21, 2025: New study reveals path to better outcomes through faster, more accurate biomarker testing
- April 4, 2025: How adaptive leadership can enhance health care ethics
- April 1, 2025: Welcome 2025 summer student researchers
- February 11, 2025: Celebrating the International Day of Women and Girls in Science
- January 13, 2025: New treatments for advanced lung cancer
- January 7, 2025: Summer Student Research Program application portal now open
- December 28, 2024: Canadian consensus recommendations: Advances in gastric cancer diagnosis and treatment
- October 31, 2024: CARE wins Patient and Family Engagement Award at 2024 North American Conference on Integrated Care
- September 17, 2024: Osler showcases 15 student research projects at annual summer student research day
- September 4, 2024: Clinical Ethics internship symposium
- July 22, 2024: New research: Improving the patient experience with Emergency Department wait times
- July 10, 2024: Researcher profile: Champica Nicholas and liquid biopsy technology
- May 13, 2024: Discussing dysphagia: Presentation at the SAC national convention
- April 2, 2024: The unique role of Osler’s Ethics Research team
- March 12, 2024: A new tool to support patients on dialysis
- March 5, 2024: Enhancing cancer care with improved biomarker proficiency testing
- March 4, 2024: Addressing missed opportunities for opioid agonist therapy
- March 1, 2024: Promoting health equity in clinical trials
